Medication-related-harm (MRH) is especially prevalent in older adults due to changing physiology as the body ages, increased frailty, and the incidence of polypharmacy in this patient group. Giovanni Furlan, Worldwide Safety Site Lead for Thessaloniki of Pfizer discusses what makes this patient group so vulnerable to adverse drug reactions, how poor represen ... Show More
Nov 21
#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing tru ... Show More
29m 9s
Oct 17
#40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities, but they have also increased the stakes. How do we use them without ... Show More
29m 1s
Oct 2024
#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
<p><a href= "https://peterattiamd.com/ama64/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=241007-pod-ama64&utm_content=241007-pod-ama64-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/?utm_source=podcast-feed ... Show More
20m 36s
Feb 2025
PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
<p>In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multi ... Show More
24m 12s
Jan 2025
#333 ‒ Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more | Steven Austad, Matt Kaeberlein, Richard Miller
<p><a href= "https://peterattiamd.com/longevityroundtable/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=250127-pod-longevityroundtable&utm_content=250127-pod-longevityroundtable-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peteratti ... Show More
2h 41m
Apr 2025
Lipoprotein(a) and Cardiovascular Disease | Geriatric Pharmacy Focus
<p>In this episode of Geriatric Pharmacy Focus, we welcome back Dr. Thomas Dayspring for an in-depth discussion on lipoprotein(a). We explore what it is, how to test for it, available treatment options, and the pharmacist's role in raising awareness for this genetic cardiovascula ... Show More
49m 19s